National Institutes of Health

Description

This funding opportunity announcement (FOA) solicits applications to fund up to two patient-centered comparative effectiveness clinical trials using a UH2/UH3 cooperative agreement mechanism. This initiative is supported by the Hypertension Disparities Reduction Program Partnership (HDRPP), a research partnership between NHLBI, NINDS, and the Patient-Centered Outcomes Research Institute (PCORI), with funds provided by PCORI to the NIH. The research initiative aims to reduce disparities in hypertension, a leading cause of cardiovascular disease that disproportionately affects certain populations including racial and ethnic minorities, individuals with low socioeconomic status, and rural communities. Approximately 30% of adults in the U.S. have hypertension, and of these, more than half have uncontrolled hypertension. The purpose of the FOA is to compare alternative, evidence-based approaches to reduce inadequate control of hypertension among high risk populations, including racial/ethnic minority groups, patients with low socioeconomic status (SES), and individuals residing in rural geographical areas with an above average lifetime risk of cardiovascular disease (CVD).

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster <br/>FBOWebmaster@OD.NIH.GOV <br/>
FBOWebmaster@OD.NIH.GOV